Affordable Access

Publisher Website

Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS).

Authors
  • 1
Type
Published Article
Journal
Child and adolescent psychiatry and mental health
1753-2000
Publication Date
Volume
2
Issue
1
Pages
11–11
Identifiers
DOI: 10.1186/1753-2000-2-11
PMID: 18507848
Source
Medline

Abstract

The emotional well-being of children and adolescents with ADHD improved in terms of depressed mood, irritability/agitation, drowsiness, and euphoria during treatment with atomoxetine for up to 24 weeks.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F